AutoCruitment
Generated 5/10/2026
Executive Summary
AutoCruitment is a San Francisco-based digital health company leveraging AI and machine learning to streamline patient recruitment for clinical trials. Founded in 2019, its platform combines a vast digital advertising network with automated pre-screening and referral to directly target and qualify patients for research sites. By reducing enrollment timelines and site burden across multiple therapeutic areas globally, AutoCruitment addresses a critical bottleneck in clinical development. The company operates in a high-demand market, as patient recruitment remains a top challenge for sponsors and CROs. With its technology-enabled approach, AutoCruitment is well-positioned to capture market share, though financial details and stage remain undisclosed.
Upcoming Catalysts (preview)
- Q3 2026Major partnership with top-10 pharma or large CRO50% success
- Q4 2026New therapeutic area expansion (e.g., oncology or rare disease)65% success
- Q3 2026Series A or B funding round announcement40% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)